Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Killer Cells, Natural | 20 | 2022 | 49 | 5.470 |
Why?
|
| HIV-1 | 19 | 2017 | 236 | 3.450 |
Why?
|
| HIV Infections | 18 | 2022 | 488 | 2.960 |
Why?
|
| Simian Immunodeficiency Virus | 5 | 2022 | 16 | 2.450 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2022 | 17 | 2.240 |
Why?
|
| Viral Regulatory and Accessory Proteins | 9 | 2016 | 15 | 2.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 12 | 2016 | 116 | 1.760 |
Why?
|
| Histocompatibility Antigens Class I | 6 | 2016 | 18 | 1.380 |
Why?
|
| Human Immunodeficiency Virus Proteins | 5 | 2016 | 5 | 1.240 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2016 | 3 | 1.060 |
Why?
|
| Cytokines | 3 | 2022 | 230 | 1.050 |
Why?
|
| Lymphocytes | 3 | 2021 | 63 | 1.010 |
Why?
|
| T-Lymphocytes | 4 | 2016 | 97 | 0.960 |
Why?
|
| HLA-C Antigens | 4 | 2016 | 9 | 0.940 |
Why?
|
| Down-Regulation | 5 | 2016 | 102 | 0.900 |
Why?
|
| Antigens, CD | 5 | 2012 | 52 | 0.860 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 5 | 2016 | 8 | 0.850 |
Why?
|
| Interferon-gamma | 5 | 2022 | 82 | 0.790 |
Why?
|
| Colon | 5 | 2022 | 142 | 0.710 |
Why?
|
| Immunity, Innate | 5 | 2022 | 58 | 0.600 |
Why?
|
| Intestinal Mucosa | 4 | 2020 | 192 | 0.570 |
Why?
|
| Macaca mulatta | 3 | 2022 | 61 | 0.560 |
Why?
|
| Receptors, Virus | 1 | 2016 | 5 | 0.540 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2010 | 18 | 0.510 |
Why?
|
| Receptors, Cell Surface | 3 | 2010 | 39 | 0.500 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 14 | 0.480 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 2 | 2014 | 2 | 0.470 |
Why?
|
| Receptors, Natural Killer Cell | 4 | 2022 | 5 | 0.470 |
Why?
|
| Lymphocyte Activation | 4 | 2017 | 86 | 0.430 |
Why?
|
| Lymphocyte Subsets | 2 | 2014 | 7 | 0.410 |
Why?
|
| Receptors, Immunologic | 3 | 2007 | 28 | 0.410 |
Why?
|
| Humans | 30 | 2021 | 28408 | 0.390 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 113 | 0.390 |
Why?
|
| Cell Degranulation | 1 | 2010 | 6 | 0.360 |
Why?
|
| Animals | 5 | 2022 | 3780 | 0.360 |
Why?
|
| Granzymes | 2 | 2021 | 7 | 0.360 |
Why?
|
| Inflammation | 3 | 2022 | 284 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 192 | 0.340 |
Why?
|
| Salmonella typhimurium | 3 | 2021 | 4 | 0.340 |
Why?
|
| HIV | 2 | 2007 | 43 | 0.340 |
Why?
|
| Gene Products, vpr | 1 | 2009 | 1 | 0.330 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 16 | 0.330 |
Why?
|
| Interleukins | 2 | 2020 | 25 | 0.330 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2021 | 181 | 0.310 |
Why?
|
| HLA Antigens | 2 | 2004 | 17 | 0.290 |
Why?
|
| HTLV-I Infections | 1 | 2007 | 4 | 0.290 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2007 | 5 | 0.290 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2007 | 9 | 0.290 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 13 | 0.290 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 20 | 0.280 |
Why?
|
| Flow Cytometry | 6 | 2017 | 116 | 0.280 |
Why?
|
| HLA-B Antigens | 4 | 2016 | 8 | 0.280 |
Why?
|
| Transcription Factors | 1 | 2007 | 172 | 0.260 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 281 | 0.260 |
Why?
|
| Stress, Psychological | 2 | 2018 | 241 | 0.250 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2015 | 30 | 0.230 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 3 | 2010 | 3 | 0.230 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family | 3 | 2010 | 4 | 0.230 |
Why?
|
| Genetic Vectors | 2 | 2006 | 60 | 0.220 |
Why?
|
| Cullin Proteins | 2 | 2015 | 2 | 0.210 |
Why?
|
| GPI-Linked Proteins | 4 | 2014 | 21 | 0.210 |
Why?
|
| Cell Line | 3 | 2010 | 280 | 0.200 |
Why?
|
| Th17 Cells | 1 | 2022 | 30 | 0.200 |
Why?
|
| Ruminococcus | 1 | 2021 | 1 | 0.190 |
Why?
|
| Acinetobacter | 1 | 2021 | 2 | 0.190 |
Why?
|
| Interleukin-15 | 1 | 2021 | 8 | 0.190 |
Why?
|
| Interleukin-17 | 1 | 2020 | 18 | 0.170 |
Why?
|
| Ligands | 3 | 2014 | 41 | 0.170 |
Why?
|
| DNA Damage | 2 | 2010 | 28 | 0.170 |
Why?
|
| Dendritic Cells | 1 | 2019 | 32 | 0.170 |
Why?
|
| Gram-Positive Bacteria | 1 | 2019 | 13 | 0.160 |
Why?
|
| Gram-Negative Bacteria | 1 | 2019 | 29 | 0.160 |
Why?
|
| Underage Drinking | 1 | 2018 | 1 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2018 | 1 | 0.160 |
Why?
|
| Tobacco Use | 1 | 2018 | 8 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 53 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 80 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2009 | 55 | 0.150 |
Why?
|
| Interleukin-2 | 2 | 2008 | 24 | 0.150 |
Why?
|
| Receptors, CCR7 | 2 | 2015 | 7 | 0.150 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 17 | 0.150 |
Why?
|
| Conduct Disorder | 1 | 2017 | 3 | 0.140 |
Why?
|
| Facial Expression | 1 | 2017 | 9 | 0.140 |
Why?
|
| Dysbiosis | 1 | 2017 | 56 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 97 | 0.140 |
Why?
|
| Pattern Recognition, Visual | 1 | 2017 | 18 | 0.140 |
Why?
|
| Membrane Proteins | 2 | 2009 | 171 | 0.140 |
Why?
|
| DNA Methylation | 1 | 2018 | 165 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 37 | 0.140 |
Why?
|
| Membrane Glycoproteins | 2 | 2007 | 72 | 0.140 |
Why?
|
| Emotions | 1 | 2017 | 78 | 0.140 |
Why?
|
| Social Environment | 1 | 2017 | 81 | 0.130 |
Why?
|
| Cell Death | 1 | 2016 | 46 | 0.130 |
Why?
|
| Receptors, KIR3DL1 | 1 | 2016 | 1 | 0.130 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2016 | 1 | 0.130 |
Why?
|
| HIV Seropositivity | 2 | 2007 | 51 | 0.120 |
Why?
|
| Peptides | 1 | 2016 | 103 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 11 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2014 | 106 | 0.110 |
Why?
|
| Cell Movement | 1 | 2014 | 82 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2012 | 34 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2014 | 56 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2016 | 539 | 0.110 |
Why?
|
| Selection, Genetic | 1 | 2012 | 4 | 0.100 |
Why?
|
| Immunophenotyping | 2 | 2014 | 29 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 1143 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2012 | 32 | 0.100 |
Why?
|
| Male | 5 | 2020 | 15273 | 0.090 |
Why?
|
| Female | 5 | 2020 | 15708 | 0.090 |
Why?
|
| Jurkat Cells | 1 | 2010 | 10 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2010 | 42 | 0.090 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 5 | 0.080 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2009 | 14 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 139 | 0.080 |
Why?
|
| Stem Cells | 1 | 2009 | 41 | 0.080 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 56 | 0.080 |
Why?
|
| Apoptosis | 1 | 2010 | 205 | 0.080 |
Why?
|
| Gene Expression | 1 | 2009 | 202 | 0.080 |
Why?
|
| Monocytes, Activated Killer | 1 | 2008 | 1 | 0.080 |
Why?
|
| HLA-A Antigens | 2 | 2008 | 13 | 0.080 |
Why?
|
| Viremia | 1 | 2007 | 9 | 0.070 |
Why?
|
| Brain | 1 | 2017 | 1663 | 0.070 |
Why?
|
| Coculture Techniques | 1 | 2007 | 28 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2007 | 32 | 0.070 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2007 | 1 | 0.070 |
Why?
|
| CD48 Antigen | 1 | 2007 | 3 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2007 | 31 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2007 | 71 | 0.070 |
Why?
|
| Retinal Degeneration | 1 | 2006 | 2 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 15 | 0.070 |
Why?
|
| Lentivirus | 1 | 2006 | 11 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 2004 | 9 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2004 | 16 | 0.060 |
Why?
|
| Receptors, KIR | 1 | 2004 | 1 | 0.060 |
Why?
|
| K562 Cells | 1 | 2004 | 3 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2004 | 4 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 160 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 199 | 0.050 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2003 | 9 | 0.050 |
Why?
|
| Cell Separation | 1 | 2003 | 29 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2003 | 44 | 0.050 |
Why?
|
| Adolescent | 2 | 2018 | 2307 | 0.050 |
Why?
|
| Time Factors | 1 | 2004 | 1490 | 0.040 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 24 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 2019 | 23 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2018 | 6 | 0.040 |
Why?
|
| Organ Size | 1 | 2018 | 100 | 0.040 |
Why?
|
| Gray Matter | 1 | 2018 | 51 | 0.040 |
Why?
|
| Alleles | 1 | 2018 | 221 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 86 | 0.040 |
Why?
|
| Colitis | 1 | 2017 | 37 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2017 | 17 | 0.040 |
Why?
|
| Amygdala | 1 | 2017 | 41 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2017 | 65 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 439 | 0.030 |
Why?
|
| Cyclopentanes | 1 | 2015 | 1 | 0.030 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2015 | 2 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2015 | 22 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 2015 | 29 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2014 | 21 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 18 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 60 | 0.030 |
Why?
|
| Protein Binding | 1 | 2014 | 132 | 0.030 |
Why?
|
| Chemokine CCL19 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 932 | 0.030 |
Why?
|
| CD56 Antigen | 1 | 2014 | 2 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 67 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2014 | 15 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2014 | 12 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 6 | 0.030 |
Why?
|
| Virus Release | 1 | 2012 | 6 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2012 | 37 | 0.030 |
Why?
|
| Binding Sites | 1 | 2012 | 75 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2012 | 148 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2012 | 54 | 0.020 |
Why?
|
| Viral Load | 1 | 2012 | 73 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2012 | 71 | 0.020 |
Why?
|
| Adult | 2 | 2014 | 8097 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 9254 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2008 | 10 | 0.020 |
Why?
|
| Virus Replication | 1 | 2008 | 51 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 213 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 178 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 2069 | 0.020 |
Why?
|
| Retina | 1 | 2006 | 8 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 23 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 26 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 45 | 0.020 |
Why?
|
| Injections | 1 | 2006 | 44 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 29 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 435 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 1461 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 1549 | 0.010 |
Why?
|